A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Kelly Faulk
Study ID
Protocol Number: 22-1254
More information available at ClinicalTrials.gov: NCT05183035
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers